> top > docs > PMC:7795856 > spans > 90-395 > annotations

PMC:7795856 / 90-395 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
18 38-41 Gene denotes Tα1 Gene:134864
20 96-113 Species denotes hepatitis B virus Tax:10407
24 115-118 Species denotes HBV Tax:10407
31 124-158 Disease denotes hepatitis C virus (HCV) infections MESH:D006526
32 237-245 Disease denotes COVID-19 MESH:C000657245
33 246-256 Disease denotes infections MESH:D007239
34 261-267 Disease denotes cancer MESH:D009369

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T2 96-105 Phenotype denotes hepatitis http://purl.obolibrary.org/obo/HP_0012115
T3 124-133 Phenotype denotes hepatitis http://purl.obolibrary.org/obo/HP_0012115
T4 261-267 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T3 16-24 Sentence denotes Abstract
T4 25-268 Sentence denotes Thymosin α1 (Tα1) is an immunostimulatory peptide for the treatment of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections and used as an immune enhancer, which also offers prospects in the context of COVID-19 infections and cancer.